Phreesia, Inc. (PHR)
Market Cap | 1.38B |
Revenue (ttm) | 356.30M |
Net Income (ttm) | -136.89M |
Shares Out | 55.63M |
EPS (ttm) | -2.51 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 666,646 |
Open | 24.19 |
Previous Close | 24.39 |
Day's Range | 23.73 - 24.99 |
52-Week Range | 12.05 - 34.98 |
Beta | 0.93 |
Analysts | Strong Buy |
Price Target | 32.73 (+36.77%) |
Earnings Date | Mar 14, 2024 |
About PHR
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to d... [Read more]
Financial Performance
In 2023, Phreesia's revenue was $356.30 million, an increase of 26.84% compared to the previous year's $280.91 million. Losses were -$136.89 million, -22.29% less than in 2022.
Financial StatementsAnalyst Forecast
According to 15 analysts, the average rating for PHR stock is "Strong Buy." The 12-month stock price forecast is $32.73, which is an increase of 36.77% from the latest price.
News
Phreesia Announces Jack Callahan as New Chief Technology Officer
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, has named Jack Callahan as the company's new Chief Technology Officer.
Phreesia Announces Fourth Quarter Fiscal 2024 Results
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2024. "Phr...
Phreesia's Hilary Hatch Again Named to the 2024-2025 NQF Leadership Consortium
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announces that its Chief Clinical Officer Hilary Hatch, PhD, has been selected to participate in NQF's 2024-2025 Leadership Consortium.
Phreesia Sets Release Date for Fiscal Fourth Quarter 2024 Results
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia will release its fiscal fourth quarter 2024 financial results after the close of market trading on Thursday, March 14, 2024.
Phreesia Joins Call to Action to Improve Adult Vaccination Rates
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia is pleased to announce it has joined the National Adult and Influenza Immunization Summit's Call to Action for Adult Immunizations campaign.
Phreesia's Audrey Gato Named as a Top Woman Leader in SaaS
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Audrey Gato, Vice President of Client Solutions, has been named to The Softw...
Phreesia's Post-Script Engagement named one of PM360's 2023 Most Innovative Technologies
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia's Post-Script Engagement has been named to PM360's list of its 2023 Most Innovative Marketing Technologies or Services.
Phreesia Announces Third Quarter Fiscal 2024 Results
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal third quarter ended October 31, 2023. "I am proud of our wo...
Phreesia Achieves HITRUST Risk-Based, 2-Year Certification Demonstrating the Highest Level of Information Protection Assurance
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia today announced its patient intake platform and data centers have earned certified status by HITRUST for information security. We believe HITRUST Risk-based...
Phreesia Sets Release Date for Fiscal Third Quarter 2024 Results
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal third quarter 2024 financial results after the close of market trading on Tue...
Phreesia Announces Second Quarter Fiscal 2024 Results
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2023. "I am incredibly please...
Phreesia Named to The Software Report's “Top 100 Software Companies” for the Second Consecutive Year
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, is pleased to announce it has been selected by The Software Report as one of the “Top 100 Software Com...
Phreesia Awards Inducement Grants as Part of its Acquisition of Access eForms
WILMINGTON, Del.--(BUSINESS WIRE)--On July 13, 2023, Phreesia, Inc.'s (“Phreesia”) Board of Directors approved the grant of restricted stock unit awards pursuant to Phreesia's 2023 Inducement Award Pl...
Phreesia Acquires Access, Expanding its Offerings for Acute-Care Hospitals and Continuing to Drive Efficiency and a Better Patient Experience
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, is pleased to announce it has acquired Access eForms, an innovative electronic forms management and au...
Phreesia Sets Release Date for Fiscal Second Quarter 2024 Results
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia will release its fiscal second quarter 2024 financial results after the close of market trading on Wednesday, September 6, 2023.
Phreesia Acquires MediFind, Reinforcing its Commitment to Patient-Centered Care and Expanding its Offerings to Consumers
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia Acquires MediFind, Reinforcing its Commitment to Patient-Centered Care and Expanding its Offerings to Consumers.
Phreesia Names Lisa Egbuonu-Davis to its Board of Directors
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has named Lisa Egbuonu-Davis, MD, MPH, MBA, as the newest member of its board of directors, effective July 13, 2023.
Phreesia Announces First Quarter Fiscal 2024 Results
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2023. "Our team got off to a ...
Phreesia Recognized as One of Modern Healthcare's “Best Places to Work in Healthcare” for a Seventh Year
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has been selected by Modern Healthcare as one of the 2023 Best Places to Work in Healthcare.
Phreesia's Hilary Hatch Named a “Disrupter” in PM360's ELITE 100
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia is pleased to announce that Hilary Hatch, PhD, Phreesia's Chief Clinical Officer, has been named as one of the 2023 PM360 ELITE 100 by healthcare-marketing ...
Phreesia Sets Release Date for Fiscal First Quarter 2024 Results
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. will release its fiscal first quarter 2024 financial results after the close of market trading on Wednesday, May 31, 2023.
Unlimited Systems Partners with Phreesia, Improving Efficiency and Offering an Integrated Patient-Driven Intake Experience for Oncology Groups
CINCINNATI & WILMINGTON, Del.--(BUSINESS WIRE)--Unlimited Systems and Phreesia are offering a new integration for independent oncology practices and health systems.
Phreesia Announces Fourth Quarter Fiscal 2023 Results
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2023. "The...
Phreesia Announces Chief Financial Officer Transition
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR), a leader in patient intake, outreach and activation, today announced the appointment of Balaji Gandhi as Phreesia's Chief Financial Offic...
Phreesia Named as One of the Achievers 50 Most Engaged Workplaces® of 2023
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has been named as one of the 2023 Achievers 50 Most Engaged Workplaces®.